GAGA Share Market News

[hfe_template id='11223'] [ad_1] The shares of Nephro Care listed on the NSE SME platform on Friday with a premium of 90%. The stock debuted at Rs 171 as against an offer price of Rs 90. Ahead of the listing, the company's shares traded with a premium of Rs 230 in the unlisted market. The IPO, which was completely a fresh equity sale of 45.84 lakh shares generated massive response among investors with an overall subscription of over 700 times at close. The Kolkata-based company plans to utilise a portion of the net proceeds from the IPO to set up a 100-bed multispeciality hospital called ‘Vivacity Multi Speciality Hospital’ at Madhyamgram in Kolkata. The remaining part of the proceeds will be utilised for general corporate purposes. The hospital will be a unit of Nephro Care India and is proposed to include 100 inpatient beds, including a 30-bed Critical Care unit having ICU, HDU, RTU and NICU facilities. Also Read: Bansal Wire IPO: Should you subscribe to the Rs 745...

[hfe_template id='11223'] [ad_1] The SME IPO of Nephro Care opened for subscription earlier today and will close on July 2. The company aims to raise about Rs 41.26 crore through the SME IPO and list the shares on NSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue. 1) About Nephro Care Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. 2) Industry overview CKD is a severe public health issue in India. As per government estimates, nearly 2,20,000 patients develop end-stage renal disease (ESRD) annually in India, leading to an additional annual dialysis demand of 34 million treatment sessions. Unfortunately, in India, renal insufficiency treatment focuses more on curati...